Filter
2923
Filtered Results: 2923
Text search:
World
Health
Organization
WHO,
Regional
Office
for
Africa
Featured
Recommendations
278
New Publications
778
Language
Document type
No document type
1617
Studies & Reports
564
Guidelines
332
Manuals
146
Strategic & Response Plan
123
Training Material
50
Fact sheets
38
Situation Updates
35
Resource Platforms
8
Infographics
5
Brochures
2
Online Courses
2
App
1
Countries / Regions
Global
140
Ethiopia
108
Kenya
98
Sierra Leone
91
Africa
88
Liberia
85
Uganda
73
Zambia
61
South Africa
59
Nigeria
58
Ghana
51
Tanzania
49
Malawi
48
Western and Central Europe
39
India
37
Mozambique
37
West and Central Africa
36
East and Southern Africa
35
Rwanda
34
Guinea
33
Namibia
32
South Sudan
31
Syria
29
Congo, Democratic Republic of
28
Middle East and North Africa
28
Nepal
26
Lesotho
25
Senegal
24
Asia
22
South–East Asia Region
20
Zimbabwe
19
Latin America and the Carribbean
19
Ukraine
18
Yemen
17
Bangladesh
15
Central African Republic
15
Eswatini/ Swaziland
15
Eastern Europe
15
Cameroon
14
Somalia
14
Angola
14
Botswana
13
Myanmar / Burma
12
Pakistan
11
Madagascar
11
Burkina Faso
10
Guinea-Bissau
9
Afghanistan
9
Sudan
9
Brazil
9
Russia
9
Mali
8
Philippines
8
Cambodia
8
Haiti
7
Thailand
7
China
7
Indonesia
7
Benin
7
Eastern Europe and Central Asia
7
Colombia
6
Western Pacific Region
6
Venezuela
6
Côte d’Ivoire / Ivory Coast
5
Jordan
5
Lebanon
5
Gambia
5
Togo
4
Chad
4
Burundi
4
Sri Lanka
4
Southern Africa
4
Iran
4
Iraq
3
Papua New Guinea
3
Peru
3
North Macedonia
3
Mexico
3
Georgia
3
Mauritius
3
Morocco
2
USA
2
Saudi Arabia
2
Germany
2
Greece
2
Albania
2
Djibouti
2
Laos
2
Moldova
2
Kyrgyzstan
2
Kazakhstan
2
Vietnam
2
North America
2
Portugal
2
Bosnia and Herzegovina
2
Niger
1
Turkey
1
Mauritania
1
Vanuatu
1
Argentina
1
Serbia
1
Hungary
1
Ecuador
1
Libya
1
Solomon Islands
1
Palestine
1
North Korea
1
Armenia
1
Canada
1
Timor Leste/ East Timor
1
Tajikistan
1
Qatar
1
Bulgaria
1
Estonia
1
Gabon
1
Turkmenistan
1
Jamaica
1
Japan
1
Belgium
1
Tunisia
1
United Kingdom
1
Norway
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
980
Clinical Guidelines
220
Public Health
174
Women & Child Health
169
Key Resources
151
Capacity Building
54
Pharmacy & Technologies
34
Toolboxes
HIV
264
COVID-19
236
Mental Health
187
Planetary Health
144
Disability
136
TB
135
Rapid Response
131
Ebola
127
AMR
89
Conflict
78
Global Health Education
72
NTDs
70
Caregiver
69
Refugee
65
Pharmacy
49
NCDs
39
Natural Hazards
35
Health Financing Toolbox
34
Zika
20
Cholera
16
Polio
15
Specific Hazards
7
Social Ethics
6
Typhoon
3
South Sudan
1
Руководство по осуществлению mhGAP
recommended
The WHO Mental Health Gap Action Programme (mhGAP) aims at scaling up mental health services in non-specialized ... settings to achieve universal health coverage. The mhGAP operations manual is an integral component of the mhGAP package and supports district health managers and others responsible for integrating mental and physical health services. The manual offers practical guidance and necessary tools for planning, preparing, implementing, monitoring and evaluating mhGAP
The mhGAP community toolkit: field test version is an integral part of WHO's Mental Health Gap Action Programme (mhGAP), and aims at scaling up services f... people with mental health conditions to achieve universal health coverage.
The toolkit provides guidance for programme managers on how to identify local mental health needs and tailor community services to match these needs. It offers practical information and necessary tools for community providers to promote mental health, prevent mental health conditions and expand access to mental health services.
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for ... and continue to experience stigmatization, institutionalization, barriers to access health care and inequalities in health and education outcomes.
Using findings from research and practice and guided by the tenets of international human rights conventions, this WHO-UNICEF Global Report on children with developmental disabilities provides principles and approaches to intentionally include the needs and aspirations of children and young people with developmental disabilities in policy, programming and public health monitoring. It makes the case for greater accountability and proposes 10 priority actions to accelerate changes towards inclusive environments and responsive multisectoral care systems for children with developmental disabilities.
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for...
Guideline
Iron deficiency is one of the most common forms of nutritional deficiencies, particularly among vulnerable groups such as women, children and low-income populations. Iron deficiency often precedes anaemia, and anaemia during pregnancy is one of the strongest predictors of anaemia duri...
Iron deficiency is one of the most common forms of nutritional deficiencies, particularly among vulnerable groups such as women, children and low-income populations. Iron deficiency often precedes anaemia, and anaemia during pregnancy is one of the strongest predictors of anaemia duri...
Policy brief, 24 July 2020
The COVID-19 pandemic has affected older people disproportionately, especially those living in long-term care facilities. In many countries, evidence shows that more than 40% of COVID-19 related deaths have been linked to long-term care facilities, with figures being as h...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity ... quality-assured implementation. Therefore, the main objective of this manual is to provide practical tools, techniques and procedures to strengthen sand fly control and surveillance in order to improve implementation of leishmaniasis control programmes. The manual provides a rationale for programme managers in different geographical regions on the types of vector control interventions to be used in different epidemiological and environmental settings and also how to measure their impact.
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e...
Lack of trained providers capable of identifying which labouring women could benefit from assisted vaginal birth (AVB), and of safely performing the procedure is a major barrier for its use. Education and training are, therefore, considered crucial ...
Countries are making progress toward the global goal of 95% of people living with HIV knowing their status by 2025. However, considerable gaps remain in achieving these goals globally. Men in high HIV burden settings and men from key populations in all settings are consistently less likely to know t...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified ... care provider and do not receive the necessary care in a timely fashion. Without rapid detection of danger signs and access to effective treatment, including pre-referral treatment that can be administered in the community level, many of these children with severe malaria die.
In situations where there is no immediate access to a health care facility, WHO recommends the administration of a standard dose of an effective antimalarial medicine as pre-referral treatment before referral to a facility at which complete treatment can be administered.
Rectal artesunate is the WHO-recommended pre-referral intervention in situations where artesunate injection are not feasible for children under the age of 6 years with suspected severe malaria. The intervention reduces the risk of death or permanent disability by up to 50% provided the child is referred to a health facility at which complete treatment can be administered.
This field guide is aimed at supporting the effective deployment of RAS as pre-referral treatment of suspected severe malaria in line with the WHO malaria guidelines.
Quality of care in fragile, conflict-affected and vulnerable settings: tools and resources compendium
recommended
This compendium represents a curated, pragmatic and non-prescriptive collection of tools and resources to support the implementation of interventions to improve quality of care in such contexts. Relevant tools and resources are listed under five areas: Ensuring access and basic infrastructure ... quality; shaping the system environment; reducing harm; improving clinical care; and engaging and empowering patients, families and communities.
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto gl...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual pro...
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and
training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG)
for MNS disorders in non-specialized ... settings (8) is a clinical decision-making tool
for assessing and managing priority MNS conditions (depression, psychoses, epilepsy, child
and adolescent mental and behavioural disorders, dementia, disorders due to substance
use, self-harm and suicide).
The far-reaching impacts of the COVID-19 pandemic underscore the critical need for evidence-informed, transparent and inclusive decision-making. Policy-makers have grappled with complex choices amidst uncertainty. They have constantly reassessed res...
